ArticleFrontiers in immunology2022

CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancer.

Tianyi Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.